• Login
    View Item 
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles
    • View Item
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    Intracranial Efficacy of Selpercatinib in Fusion-Positive Non-Small Cell Lung Cancers on the LIBRETTO-001 Trial

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Author
    Subbiah, Vivek
    Gainor, Justin F
    Oxnard, Geoffrey R
    Tan, Daniel S W
    Owen, Dwight H
    Cho, Byoung Chul
    Loong, Herbert H
    McCoach, Caroline E
    Weiss, Jared
    Kim, Yu Jung
    Bazhenova, Lyudmila
    Park, Keunchil
    Daga, Haruko
    Besse, Benjamin
    Gautschi, Oliver
    Rolfo, Christian
    Zhu, Edward Y
    Kherani, Jennifer F
    Huang, Xin
    Kang, Suhyun
    Drilon, Alexander
    Show allShow less

    Date
    2021-06-18
    Journal
    Clinical Cancer Research
    Publisher
    American Association for Cancer Research
    Type
    Article
    
    Metadata
    Show full item record
    See at
    https://doi.org/10.1158/1078-0432.CCR-21-0800
    Abstract
    We report the intracranial efficacy of selpercatinib, a highly potent and selective RET inhibitor, approved in the United States for RET fusion-positive non-small cell lung cancers (NSCLC).
    Rights/Terms
    ©2021 American Association for Cancer Research.
    Keyword
    LIBRETTO-001 Trial
    RET fusion-positive NSCLC
    selpercatinib
    Carcinoma, Non-Small-Cell Lung--drug therapy
    Identifier to cite or link to this item
    http://hdl.handle.net/10713/16059
    ae974a485f413a2113503eed53cd6c53
    10.1158/1078-0432.CCR-21-0800
    Scopus Count
    Collections
    UMB Open Access Articles

    entitlement

    Related articles

    • Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial.
    • Authors: Drilon A, Subbiah V, Gautschi O, Tomasini P, de Braud F, Solomon BJ, Shao-Weng Tan D, Alonso G, Wolf J, Park K, Goto K, Soldatenkova V, Szymczak S, Barker SS, Puri T, Bence Lin A, Loong H, Besse B
    • Issue date: 2023 Jan 10
    • Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer.
    • Authors: Drilon A, Oxnard GR, Tan DSW, Loong HHF, Johnson M, Gainor J, McCoach CE, Gautschi O, Besse B, Cho BC, Peled N, Weiss J, Kim YJ, Ohe Y, Nishio M, Park K, Patel J, Seto T, Sakamoto T, Rosen E, Shah MH, Barlesi F, Cassier PA, Bazhenova L, De Braud F, Garralda E, Velcheti V, Satouchi M, Ohashi K, Pennell NA, Reckamp KL, Dy GK, Wolf J, Solomon B, Falchook G, Ebata K, Nguyen M, Nair B, Zhu EY, Yang L, Huang X, Olek E, Rothenberg SM, Goto K, Subbiah V
    • Issue date: 2020 Aug 27
    • Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial.
    • Authors: Subbiah V, Wolf J, Konda B, Kang H, Spira A, Weiss J, Takeda M, Ohe Y, Khan S, Ohashi K, Soldatenkova V, Szymczak S, Sullivan L, Wright J, Drilon A
    • Issue date: 2022 Oct
    • Efficacy and safety of selpercatinib in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer: a phase II clinical trial (LIBRETTO-321).
    • Authors: Lu S, Cheng Y, Huang D, Sun Y, Wu L, Zhou C, Guo Y, Shao J, Zhang W, Zhou J
    • Issue date: 2022
    • LIBRETTO-432, a phase III study of adjuvant selpercatinib or placebo in stage IB-IIIA RET fusion-positive non-small-cell lung cancer.
    • Authors: Tsuboi M, Goldman JW, Wu YL, Johnson ML, Paz-Ares L, Yang JC, Besse B, Su W, Chao BH, Drilon A
    • Issue date: 2022 Sep
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.